Search research articles
Contact Us
Filters
Showing results (41-50 of 86) with videos related to
Page
of 9
Sort By:
Nature Communications
|
March 25, 2023
Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis
Deborah Cromer, Megan Steain, Arnold Reynaldi, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2018
<i>In Silico</i> Investigation of the Decline in Clinical Efficacy of Artemisinin Combination Therapies Due to Increasing Artemisinin and Partner Drug Resistance
Sophie G Zaloumis, Pengxing Cao, Saber Dini, et al.
Malaria Journal
|
February 4, 2023
Evidence for exposure dependent carriage of malaria parasites across the dry season: modelling analysis of longitudinal data
Eva Stadler, Deborah Cromer, Samson Ogunlade, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 2015
Epitope-specific CD8+ T cell kinetics rather than viral variability determine the timing of immune escape in simian immunodeficiency virus infection
Alexey P Martyushev, Janka Petravic, Andrew J Grimm, et al.
Plos Neglected Tropical Diseases
|
December 9, 2016
Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission
Paul Griffin, Cielo Pasay, Suzanne Elliott, et al.
Nature Immunology
|
June 2, 2025
Towards evidence-based immunology
David S Khoury, Deborah Cromer, Bronwyn Bailey, et al.
Emerging Infectious Diseases
|
January 24, 2023
Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection
David S Khoury, Timothy E Schlub, Deborah Cromer, et al.
Plos Pathogens
|
August 26, 2016
Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5-8 Days
Mykola Pinkevych, Stephen J Kent, Martin Tolstrup, et al.
The Lancet. Microbe
|
November 22, 2021
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
Deborah Cromer, Megan Steain, Arnold Reynaldi, et al.
The Lancet. Microbe
|
April 7, 2024
Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysis
Karen M Elias, Shanchita R Khan, Eva Stadler, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 86) with videos related to
Sort By:
Page
of 9
Nature Communications
|
March 25, 2023
Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis
Deborah Cromer, Megan Steain, Arnold Reynaldi, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2018
<i>In Silico</i> Investigation of the Decline in Clinical Efficacy of Artemisinin Combination Therapies Due to Increasing Artemisinin and Partner Drug Resistance
Sophie G Zaloumis, Pengxing Cao, Saber Dini, et al.
Malaria Journal
|
February 4, 2023
Evidence for exposure dependent carriage of malaria parasites across the dry season: modelling analysis of longitudinal data
Eva Stadler, Deborah Cromer, Samson Ogunlade, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 2015
Epitope-specific CD8+ T cell kinetics rather than viral variability determine the timing of immune escape in simian immunodeficiency virus infection
Alexey P Martyushev, Janka Petravic, Andrew J Grimm, et al.
Plos Neglected Tropical Diseases
|
December 9, 2016
Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission
Paul Griffin, Cielo Pasay, Suzanne Elliott, et al.
Nature Immunology
|
June 2, 2025
Towards evidence-based immunology
David S Khoury, Deborah Cromer, Bronwyn Bailey, et al.
Emerging Infectious Diseases
|
January 24, 2023
Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection
David S Khoury, Timothy E Schlub, Deborah Cromer, et al.
Plos Pathogens
|
August 26, 2016
Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5-8 Days
Mykola Pinkevych, Stephen J Kent, Martin Tolstrup, et al.
The Lancet. Microbe
|
November 22, 2021
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
Deborah Cromer, Megan Steain, Arnold Reynaldi, et al.
The Lancet. Microbe
|
April 7, 2024
Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysis
Karen M Elias, Shanchita R Khan, Eva Stadler, et al.
Page
of 9